At the end of May, after talks between the Health Ministry and the drugindustry were abandoned, the Danish government introduced the Reverse G-Regulation Act.
This Act requires doctors to mark prescriptions specifically to indicate if the original prescribed product may be substituted. Previously, they had to mark a G on it to indicate that generic substitution was acceptable, but now they must write an S to indicate "substitution not acceptable," or a G for synonym substitution. If the prescription is not marked, the pharmacist must supply the cheapest available substitute for the prescribed product.
Local observers say the act was rushed through parliament, with a minimum of consultation with patient groups, consultants, general practitioners or industry. The full Reverse G regulations are to be introduced gradually; the next step is to implement analog substitutions. However, problems regarding liability under the new regulations have yet to be clarified.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze